A Phase I, Placebo Controlled, Randomized, Subject-And Investigator-Blind, Sponsor-Open, Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05180999 In Healthy Adult Volunteers

Trial Profile

A Phase I, Placebo Controlled, Randomized, Subject-And Investigator-Blind, Sponsor-Open, Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05180999 In Healthy Adult Volunteers

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs PF-5180999 (Primary)
  • Indications Migraine
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 21 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to withdrawn prior to recruitment.
    • 08 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2014 to 1 Jan 2015.
    • 10 Feb 2014 Planned End Date changed from 1 Jul 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top